BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 21866303)

  • 1. Transient atrial fibrillation and risk of stroke after acute myocardial infarction.
    Bishara R; Telman G; Bahouth F; Lessick J; Aronson D
    Thromb Haemost; 2011 Nov; 106(5):877-84. PubMed ID: 21866303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient atrial fibrillation complicating acute inferior myocardial infarction: implications for future risk of ischemic stroke.
    Siu CW; Jim MH; Ho HH; Miu R; Lee SW; Lau CP; Tse HF
    Chest; 2007 Jul; 132(1):44-9. PubMed ID: 17400657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initiation of oral anticoagulation after acute ischaemic stroke or transient ischaemic attack: timing and complications of overlapping heparin or conventional treatment.
    Audebert HJ; Schenk B; Tietz V; Schenkel J; Heuschmann PU
    Cerebrovasc Dis; 2008; 26(2):171-7. PubMed ID: 18628615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Major vascular events after transient ischaemic attack and minor ischaemic stroke: post hoc modelling of incidence dynamics.
    Atanassova PA; Chalakova NT; Dimitrov BD
    Cerebrovasc Dis; 2008; 25(3):225-33. PubMed ID: 18216464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombotic treatment and the risk of death and stroke in patients with atrial fibrillation and a CHADS2 score=1.
    Gorin L; Fauchier L; Nonin E; de Labriolle A; Haguenoer K; Cosnay P; Babuty D; Charbonnier B
    Thromb Haemost; 2010 Apr; 103(4):833-40. PubMed ID: 20135077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stroke prediction using mean platelet volume in patients with atrial fibrillation.
    Ha SI; Choi DH; Ki YJ; Yang JS; Park G; Chung JW; Koh YY; Chang KS; Hong SP
    Platelets; 2011; 22(6):408-14. PubMed ID: 21599611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulant and antiplatelet therapy for stroke prevention in atrial fibrillation patients in the clinical practice of a single district hospital in Poland.
    Bednarski J; Cieszewska E; Strzelecki A; Filipiak KJ
    Kardiol Pol; 2013; 71(12):1260-5. PubMed ID: 23990227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paroxysmal atrial fibrillation is more prevalent than persistent atrial fibrillation in acute stroke and transient ischemic attack patients.
    Rizos T; Wagner A; Jenetzky E; Ringleb PA; Becker R; Hacke W; Veltkamp R
    Cerebrovasc Dis; 2011; 32(3):276-82. PubMed ID: 21893980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of anticoagulation for secondary stroke prevention in older people with non-valvular atrial fibrillation: a prospective case series study.
    Tsivgoulis G; Spengos K; Zakopoulos N; Manios E; Peppes V; Vemmos K
    Age Ageing; 2005 Jan; 34(1):35-40. PubMed ID: 15591481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of effective anticoagulation in patients with atrial fibrillation to stroke severity and survival (from the National Acute Stroke Israeli Survey [NASIS]).
    Schwammenthal Y; Bornstein N; Schwammenthal E; Schwartz R; Goldbourt U; Tsabari R; Koton S; Grossman E; Tanne D
    Am J Cardiol; 2010 Feb; 105(3):411-6. PubMed ID: 20102959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulation therapy in atrial fibrillation in combination with acute myocardial infarction influences long-term outcome: a prospective cohort study from the Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA).
    Stenestrand U; Lindbäck J; Wallentin L;
    Circulation; 2005 Nov; 112(21):3225-31. PubMed ID: 16301355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of atrial fibrillation after stroke and the risk of recurrent stroke.
    Kamel H; Johnson DR; Hegde M; Go AS; Sidney S; Sorel M; Hills NK; Johnston SC
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):726-31. PubMed ID: 21546265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The quality of anticoagulation on functional outcome and mortality for TIA/stroke in atrial fibrillation patients.
    Poli D; Antonucci E; Marcucci R; Mannini L; Falciani M; Abbate R; Gensini GF; Prisco D
    Int J Cardiol; 2009 Feb; 132(1):109-13. PubMed ID: 18180057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial Fibrillation Diagnosis Timing, Ambulatory ECG Monitoring Utilization, and Risk of Recurrent Stroke.
    Lip GY; Hunter TD; Quiroz ME; Ziegler PD; Turakhia MP
    Circ Cardiovasc Qual Outcomes; 2017 Jan; 10(1):. PubMed ID: 28096204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
    Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
    Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF.
    Hankey GJ; Patel MR; Stevens SR; Becker RC; Breithardt G; Carolei A; Diener HC; Donnan GA; Halperin JL; Mahaffey KW; Mas JL; Massaro A; Norrving B; Nessel CC; Paolini JF; Roine RO; Singer DE; Wong L; Califf RM; Fox KA; Hacke W;
    Lancet Neurol; 2012 Apr; 11(4):315-22. PubMed ID: 22402056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of ximelagatran on ischemic events and death in patients with atrial fibrillation after acute myocardial infarction in the efficacy and safety of the oral direct thrombin inhibitor ximelagatran in patients with recent myocardial damage (ESTEEM) trial.
    Tangelder MJ; Frison L; Weaver D; Wilcox RG; Bylock A; Emanuelsson H; Held P; Oldgren J
    Am Heart J; 2008 Feb; 155(2):382-7. PubMed ID: 18215612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of atrial fibrillation with concurrent holter monitoring and continuous cardiac telemetry following ischemic stroke and transient ischemic attack.
    Lazzaro MA; Krishnan K; Prabhakaran S
    J Stroke Cerebrovasc Dis; 2012 Feb; 21(2):89-93. PubMed ID: 20656504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective study of total healthcare costs associated with chronic nonvalvular atrial fibrillation and the occurrence of a first transient ischemic attack, stroke or major bleed.
    Boccuzzi SJ; Martin J; Stephenson J; Kreilick C; Fernandes J; Beaulieu J; Hauch O; Kim J
    Curr Med Res Opin; 2009 Dec; 25(12):2853-64. PubMed ID: 19916729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long-term risk of stroke in patients with acute myocardial infarction complicated with new-onset atrial fibrillation.
    Asanin MR; Vasiljevic ZM; Matic MD; Mrdovic IB; Perunicic JP; Matic DP; Vujisic-Tesic BD; Stankovic SD; Matic DM; Ostojic MC
    Clin Cardiol; 2009 Aug; 32(8):467-70. PubMed ID: 19685521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.